China Resources Pharmaceutical Group Limited (3320) — Hong Kong Stock Chart & News | StockAdder

(3320)

China Resources Pharmaceutical Group Limited

Live chart and latest 3320 stock news.

Market ETF → EWH Hong Kong

Chart powered byTradingView— professional charts for every trader.Try it free →

3320 News

China Resources Pharmaceutical Completes First Tranche of 2026 PRC Bond Issuance

Mar 27, 2026 simplywall.st

China Resources Pharmaceutical Group SEHK 3320 Earnings Growth Reinforces Bullish Narrative Despite Thin Margins

Mar 26, 2026 marketscreener.com

China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025

Mar 24, 2026 TipRanks

China Resources Pharmaceutical Declares Final 2025 Dividend With Currency Option

Mar 24, 2026 simplywall.st

Take Care Before Diving Into The Deep End On China Resources Pharmaceutical Group Limited (HKG:3320)

Jan 27, 2026 TipRanks

China Resources Pharmaceutical Delivers Higher Revenue and Profit in 2025

Mar 24, 2026 simplywall.st

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

Mar 30, 2026 TipRanks

China Resources Pharma Subsidiary KPC Posts Profit Slump but Maintains Dividend

Mar 19, 2026 Growth Dragons

China Resources: From Snow Beer to Microchips - How One Company Touches Every Part of Life in China

Sep 3, 2025 AASTOCKS.com

Nomura Lowers China Resources Pharmaceutical (03320.HK) TP to HKD7.52, Maintains 'Buy' Rating

Mar 25, 2026 TipRanks

China Resources Pharma Subsidiary Dong-E-E-Jiao Lifts 2025 Profit and Proposes Higher Dividend

Mar 19, 2026 The Standard (HK)

Pharma breaks new ground with dividend

Aug 30, 2024 TipRanks

China Resources Pharmaceutical Plans Further Stake Sale in Tianmai Biotechnology

Mar 16, 2026 Reuters

China online insurer ZhongAn prices Hong Kong IPO at top end, raises $1.5 billion - IFR

Sep 21, 2017 TipRanks

CR Sanjiu Posts Strong Asset and Revenue Growth, Boosts Dividend for 2025